sitagliptin/metformin medical valley 50 mg / 1000 mg
medical valley invest ab - sitagliptinhydroklorid / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 1000 mg
sitagliptin/metformin sandoz 50 mg / 1000 mg
sandoz - københavn - sitagliptinhydrokloridmonohydrat / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 1000 mg
sitagliptin/metformin sandoz 50 mg / 850 mg
sandoz - københavn - sitagliptinhydrokloridmonohydrat / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 850 mg
sitagliptin glenmark 50 mg
glenmark arzneimittel gmbh - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 50 mg
sitagliptin glenmark 25 mg
glenmark arzneimittel gmbh - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 25 mg
sitagliptin glenmark 100 mg
glenmark arzneimittel gmbh - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 100 mg
sitagliptin hexal 50 mg
hexal a/s - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 50 mg
sitagliptin hexal 25 mg
hexal a/s - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 25 mg
sitagliptin hexal 100 mg
hexal a/s - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 100 mg
livtencity
takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirusinfeksjoner - antivirale midler til systemisk bruk - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). det bør vurderes å offisielle retningslinjer for riktig bruk av antivirale midler.